Concepedia

Scarlett Hellot

SH

Statistics

Publications

6

Citations

359

H-Index

6

Active since

2005

Affiliations

UCB Pharma (Germany)(Current)

UCB Pharma (Belgium)

Hertie Institute for Clinical Brain Research

Scarlett Hellot is an author at UCB Pharma (Germany) specializing in medicine, patient safety, and clinical trials.

Top concepts

Publications per year

2005–2020

6

Publications

6

Intraarticular Sprifermin (Recombinant Human Fibroblast Growth Factor 18) in Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Stefan Lohmander, Scarlett Hellot, Don Dreher et al. · Arthritis & Rheumatology · 2014 · 252 citations

Effectiveness and tolerability of lacosamide as add‐on therapy in patients with brain tumor–related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES)

Roberta Rudà, Caroline Houillier, Marta Maschio et al. · Epilepsia · 2020 · 51 citations · Full text

Effectiveness and tolerability of adjunctive brivaracetam in patients with focal seizures: Second interim analysis of 6-month data from a prospective observational study in Europe

Bernhard J. Steinhoff, Jakob Christensen, Colin P. Doherty et al. · Epilepsy Research · 2020 · 21 citations · Full text

, , +19

Development and psychometric validation of a new patient satisfaction instrument: The osteoARthritis Treatment Satisfaction (ARTS) questionnaire

J. Pouchot, Elyse Trudeau, Scarlett Hellot et al. · Quality of Life Research · 2005 · 14 citations

, , +8

Brivaracetam substituting other antiepileptic treatments: Results of a retrospective study in German epilepsy centers

Holger Lerche, Susanne Knake, Felix Rosenow et al. · Epilepsia Open · 2020 · 11 citations · Full text

1–5 of 6